Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates
REGULUS THERAP (NASDAQ: RGLS) Delayed: 8.16 --0 (-0%)
Previous Close $8.16    52 Week High $10.60 
Open $8.16    52 Week Low $2.13 
Day High $8.16    P/E 0.21 
Day Low $8.16    EPS $38.45 
Volume 131